Governments are running out of rescue money — hide in Imperial Brands' fat dividend and £1.5B buyback
When a top central banker says governments can no longer reliably bail out the economy, it's a signal that the next downturn could be harsher and longer than usual — a strong argument for owning businesses that don't need rescuing. Tobacco is the classic defensive sector: people keep buying regardless of the economy, margins are fat, and dividends are high. Imperial Brands adding a £1.5 billion buyback on top of that, right after its shares fell, gives you both a steady payout and a company actively supporting its own stock price. In a world where official support is running out, cash-generative defensive stocks are the safer place to hide.
Idea
When a top central banker says governments can no longer reliably bail out the economy, it's a signal that the next downturn could be harsher and longer than usual — a strong argument for owning businesses that don't need rescuing. Tobacco is the classic defensive sector: people keep buying regardless of the economy, margins are fat, and dividends are high. Imperial Brands adding a £1.5 billion buyback on top of that, right after its shares fell, gives you both a steady payout and a company actively supporting its own stock price. In a world where official support is running out, cash-generative defensive stocks are the safer place to hide.
Advanced Analysis — institutional-depth research report
Verdict: Great thesis, wrong price — wait for the RSI reset before touching IMBBY
The idea's cash-machine story is real where it counts: Imperial Brands generated £3.17B of free cash flow and £3.63B of operating cash flow in FY2025 — both series highs — while gross margin climbed to 21.8% and the £1.5B buyback announced per Bloomberg on October 8, 2026 continues an 18% share-count reduction since FY2022. The strongest point against is the balance sheet: debt-to-equity has marched from 1.49 in FY2022 to 2.78 by March 31, 2026, the current ratio sits at 0.74, and net income fell about 21% to £2.07B with the dividend down 9.6% year over year — leverage is doing a lot of the work behind that 42.9% ROE. On the tactics, the strategy cannot act today: IMBBY closed at $35.17 with RSI (14) at 84, needing a multi-week reset to at or below 35 before either entry arms, even though price is $0.92 above the $34.25 50-day EMA and ADX at 23.9 already clears 20. The completed backtest is encouraging but thin — four trades over nine months, three wins, 3.8% return with a 3.8% maximum drawdown, and exits filled on daily bars, so exit quality is approximate. No robust nearby-parameter setup was established, so the published rules are used as-is. The verdict flips decisively in either direction on fresh fundamentals: a confirmed FY2026 dividend restoration or deleveraging print would make this a buy on the oversold reset, while a further leverage rise or another dividend cut would turn the wait into an avoid.
Trade now: IMBBY is rallying, not pulling back — the entry needs an oversold dip first
Don't buy Imperial Brands here. The ADR closed at $35.17, up sharply, with its RSI (14) at 84.1 — the strategy needs an RSI at or below 35 before any entry can fire, and that reading is roughly 49 points away. The other conditions are already satisfied: the last close sits above the 50-day EMA at $34.25 (a $0.92 cushion) and ADX (14) at 23.9 clears the 20 trend-strength floor. What's missing is precisely the oversold dip the strategy is designed to catch, so 'wait' means letting price cool off without chasing. This is a multi-symbol setup — Imperial Brands, plus Altria, British American Tobacco, Philip Morris and QQQ each carry the same three-condition entry (price above the 50-day EMA, ADX above 20, RSI below 35, with variant entries also requiring a close crossing above the first resistance level). QQQ is the furthest from trigger: its RSI is 66.7 and ADX is 16.4, short of the 20 threshold by about 3.6 points. No robust nearby-parameter setup was established for this strategy, so the published rules are used as-is. The risk framework is fixed. Position risk is capped at 2.3% per trade with a hard stop at a 2.3% unrealized loss and a take-profit at 4.6% — roughly 2:1 reward-to-risk by design. The strategy's own completed nine-month backtest on Imperial Brands traded four times, won 75% of those trades, and returned 3.8% with a 3.8% maximum drawdown; exits were filled on daily bars, so treat those exit fills as approximate. Sizing is capped at 20% of the book per position, and the backtest evidence supports the structure but does not justify front-running an entry that hasn't triggered. Concretely, today's action is: set alerts at an RSI of 35 on IMBBY, and watch the $35.26 first resistance level — a decisive close through it after an oversold reset is the crossover variant's trigger. Below, the $35.00 and $34.55 marks are the nearest supports the stop framework leans on if a position ever gets opened.
Why the bull case still has support
The idea's core claim — that Imperial Brands is a self-rescuing defensive cash machine — is well supported by the fiscal 2025 numbers. Free cash flow came in at £3.17B for the year ended September 30, 2025, actually above the £2.89B of FY2024 and matching FY2022's £3.17B. Operating cash flow hit £3.63B, the highest in the five-year series. That is exactly the cash-generation profile the thesis needs: a business that funds its own payout and buyback without begging for fiscal support. Profitability quality is also improving where it matters. Gross margin has expanded steadily from 18.5% in FY2022 to 21.8% in FY2025, and operating margin has held around 10.8-11.0% for four straight years. Return on equity of 42.9% in FY2025 remains exceptional even after falling from FY2024's 48.0%. Revenue is essentially flat — £32.2B in FY2025 versus £32.6B in FY2022 — which is the trade-off, but for a value/defensive profile, stable top-line with widening gross margin is…
Scores
- Conviction score breakdown: 48
- Thesis support: 60
- Trade readiness: 20
- Risk quality: 60
- Backtest evidence: 55
- Fundamentals trend: 45
Watch items
- IMBBY — RSI (14)
- IMBBY — Close vs first resistance
- IMBBY — Close vs 50-day EMA
- QQQ — ADX (14)
- QQQ — RSI (14)
- IMBBY — Next ex-dividend date